MCK
MCKESSON CORP
NYSE · Healthcare · Medical - Distribution · US
$874.65
−0.56%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $11
- Revenue estimate
- $109.9B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $9.93
- EPS estimate
- $9.56
- Revenue actual
- $105.4B
- Revenue estimate
- $103.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +4.0%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $981
- PT range
- $845 – $1.1K
- Analysts
- 7
5 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $9.56 | $9.93 | Beat 3.87% | $105.4B |
| May 7, 2026 | $12 | $12 | Beat 1.12% | $96.3B |
| Feb 4, 2026 | $9.17 | $9.34 | Beat 1.85% | $106.2B |
| Nov 5, 2025 | $9.03 | $9.86 | Beat 9.19% | $103.2B |
| Aug 6, 2025 | $8.14 | $8.26 | Beat 1.47% | $97.8B |
| May 8, 2025 | $9.83 | $10 | Beat 2.95% | $90.8B |
| Feb 5, 2025 | $8.60 | $8.03 | Miss -6.63% | $95.3B |
| Feb 7, 2024 | $7.04 | $7.74 | Beat 9.94% | $80.9B |
| Nov 1, 2023 | $6.15 | $6.23 | Beat 1.30% | $77.2B |
| Aug 2, 2023 | $5.87 | $7.27 | Beat 23.85% | $74.5B |
| Feb 1, 2023 | $6.35 | $6.90 | Beat 8.66% | $70.5B |
| Nov 1, 2022 | $6.09 | $6.06 | Miss -0.49% | $70.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026